DR. THOMAS D FITZSIMMONS MD NPI 1275581365

NPI Details

DR. Thomas D Fitzsimmons, MD is an ophthalmology in Bend, OR with 40 years of experience. The provider is an ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses. DR. Thomas D Fitzsimmons, MD NPI is 1275581365. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Graduation Year:1986

The provider's business location address is:

1501 NE MEDICAL CENTER DR
BEND, OR
ZIP 97701-051
Phone: (541) 382-2811

The NPI 1275581365 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Photography of content of eyes (HCPCS:92285)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Exam of visual field with limited testing (HCPCS:92081)
• Established patient problem focused exam of visual system (HCPCS:92012)
• New patient problem focused exam of visual system (HCPCS:92002)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Removal of growth of eyelid (HCPCS:67840)
• Probing of nasal tear duct (HCPCS:68840)
• Removal of excessive skin and fat of upper eyelid (HCPCS:15823)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Repair of tendon of upper eyelid (HCPCS:67904)
• Extensive repair of turning-outward eyelid defect (HCPCS:67917)
• Exam of visual field with extended testing (HCPCS:92083)
• Probing of nasal tear duct with insertion of tube or stent (HCPCS:68815)
• Removal of up to 1/4 of eyelid margin and repair of eyelid (HCPCS:67961)
• Snip incision of tear duct at inner corner of eye (HCPCS:68440)
• Removal of eyelashes using forceps (HCPCS:67820)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11440)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/4/2006 and was last updated on 3/29/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.